Tracy M. Frech,
MD, MS
Languages Spoken: English, Spanish
Tracy M. Frech, M.D., M.S. completed a combined Internal Medicine-Pediatrics internship and residency at the University of Utah in 2005. She then finished a two-year Rheumatology fellowship in 2007 and Master in Clinical Investigation in 2009. Upon completion of her fellowship she joined the faculty in the Division of Rheumatology, and is currently an associate professor. She received a certification in Personalized Medicine in 2014.
She serves as the Director of the Systemic Sclerosis (SSc, scleroderma) Clinic at the University of Utah Hospital and the Director of Clinical Trials for the Division of Rheumatology. Her research interests include the vascular aspects of autoimmune disease, primarily vascular leak and SSc. She has participated in many government, foundation, and industry sponsored single and multi-center clinical trials. She has published over a hundred articles in peer review journals and several book chapters on SSc. She provides mentorship to medical students, with a focus on improving their early research experiences.
Clinical Locations
Rheumatology, Area E
801-581-7724
Fax: (801) 581-6063
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Adjunct Associate Professor |
| Academic Divisions | Rheumatology |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
February 22, 2022
UH HOSPITALS AND CLINICS
WOW! What can be said about Dr. Frech. She is the most incredible Rheumatologist I have ever had since I was diagnosed in 2000 with auto-immune disease. I have been a patient at UCLA and Stanford for Rheumatology however, I never felt at those centers I received the most thorough or comprehensive care that I received in just a few short months here at U of U health. Dr. Frech is Gold, give her the support and recognition she deserves as her patients are truly under the best care possible with her.
UofU Patient
February 22, 2022
UH HOSPITALS AND CLINICS
Dr Freck is always caring and never is in a hurry and always willing to listen to my concerns.
UofU Patient
February 20, 2022
UH HOSPITALS AND CLINICS
Dr Frech and Nurse Kelly kindly arranged very much needed referrals and follow up care for my medical needs
UofU Patient
January 31, 2022
UH HOSPITALS AND CLINICS
Dr. Frech is the best you can ask for!!
UofU Patient
January 30, 2022
UH HOSPITALS AND CLINICS
Dr. Frech is amazing, a great listener, so glad she's back at the U. She gives level 5 care. The U should be proud to have her as a team member.
UofU Patient
January 24, 2022
UH HOSPITALS AND CLINICS
I love Dr Frech. She is amazing and always is thorough and caring about my condition.
UofU Patient
November 09, 2021
UH HOSPITALS AND CLINICS
Dr. Frech has always provided care above and beyond!!! She is priceless to me! I am so thankful to have a physician specializing in the treatment of scleroderma so near to my home.
UofU Patient
November 02, 2021
UH HOSPITALS AND CLINICS
Dr. Frech is a phenomenal provider. She is extremely kind and caring and is up to date on the latest research and best practice. I feel confident trusting my care to her. She's truly one in a million when it comes to providers!
UofU Patient
August 31, 2021
UH HOSPITALS AND CLINICS
Dr. Frech is very knowledgeable and caring. I am so very thankful that she is able to continue to be my care provider!
UofU Patient
August 31, 2021
UH HOSPITALS AND CLINICS
The dr. Is a rock star. She understands my condition, always has great suggest ideas and is very personable.
UofU Patient
August 31, 2021
UH HOSPITALS AND CLINICS
Dr Frech is the best!
UofU Patient
August 02, 2021
UH HOSPITALS AND CLINICS
Dr. Frech is AWESOME. I don't know where I'd be without her expertise for my particular disease. She's always very attentive and concerned with how I'm doing. She seriously deserves a raise!
UofU Patient
July 31, 2021
UH HOSPITALS AND CLINICS
Dr. Frech is absolutely the best.
UofU Patient
June 01, 2021
UH HOSPITALS AND CLINICS
Dr Freck was awesome she addressed all my health concerns. Was great in discussing how to move forward. One of the best.
UofU Patient
May 29, 2021
UH HOSPITALS AND CLINICS
she is the best and only dr to treat my sclersderma
UofU Patient
May 24, 2021
UH HOSPITALS AND CLINICS
I tell everyone about how great this clinic and my Dr's are
UofU Patient
May 22, 2021
UH HOSPITALS AND CLINICS
Dr Frech is absolutely the best!
UofU Patient
May 17, 2021
UH HOSPITALS AND CLINICS
Dr. Frech is the most caring doctor I have ever had. I look forward to visits with her because I know that she will listen to any concerns I have, big or small.
UofU Patient
April 24, 2021
UH HOSPITALS AND CLINICS
very good. very knowledgeable and caring
UofU Patient
April 19, 2021
UH HOSPITALS AND CLINICS
dr Frech is a wonderfully knowledgeable doctor. Her bedside manner is excellent. I am blessed to have her as my doctor.
UofU Patient
April 01, 2021
UH HOSPITALS AND CLINICS
wonderful Dr., very caring
UofU Patient
March 07, 2021
UH HOSPITALS AND CLINICS
great doctor
UofU Patient
December 06, 2020
UH HOSPITALS AND CLINICS
dr Frech is a wonderful doctor
UofU Patient
December 04, 2020
UH HOSPITALS AND CLINICS
It took some time to go through the new patient review (where they decided if they would be able to help and see me), but the wait for my appt was well worth it. I felt listened to and felt like every avenue was going to be exhausted by Dr. Frank (sp sorry). it was the best experience I have ever had with a health care provider.
UofU Patient
December 04, 2020
UH HOSPITALS AND CLINICS
Tracy Frech is an amazing provider. It is obvious that she cares about each patient and also the dynamics in a patients life that can affect disease processes. My husband accompanied me to the appointment and she carefully explained the disease process and how stress can impact disease outcomes. We as a team discussed methods on decreasing stress as well as treatment strategies for my chronic disease. We felt that we came to treatment decisions together as a conversation. Dr. Frech is the epitome of what a doctor should be - caring and treating the patient as a whole individual with a team based approach with the patient and the patients advocate on the same team working cohesively.
UofU Patient
November 27, 2020
UH HOSPITALS AND CLINICS
Dr. Tracy Frech is an excellent physician in her field. I always enjoy visiting with her.
UofU Patient
November 05, 2020
UH HOSPITALS AND CLINICS
So impressed with Dr Frech's explanation, concern, examination, andallowing for questions. Top notch doctor.
UofU Patient
October 18, 2020
UH HOSPITALS AND CLINICS
Dr. Frech really knows her stuff and has helped me for the past 6 years.
UofU Patient
October 06, 2020
UH HOSPITALS AND CLINICS
LOVE Dr. Frech....thorough, caring, smart
UofU Patient
October 04, 2020
UH HOSPITALS AND CLINICS
I saw Drs Melendez, Frech, and Sholand! they were so good
UofU Patient
September 26, 2020
UH HOSPITALS AND CLINICS
She is always good at listening to me and very helpful in resolving the issues.
UofU Patient
August 30, 2020
UH HOSPITALS AND CLINICS
my issue is not with Dr Frech. It was in support staff. (I also had problems with my initial referral to Dr Frech at the end of 2019; but that also does NOT reflect on Dr Frech.)
UofU Patient
August 19, 2020
UH HOSPITALS AND CLINICS
it was hard to understand everything dr was saying because of masks and distance.
UofU Patient
August 16, 2020
UH HOSPITALS AND CLINICS
Dr Frech demonstrates care for the whole person, which I greatly appreciate.
UofU Patient
August 15, 2020
UH HOSPITALS AND CLINICS
Dr Frech is amazing! She truly cares about your well being.
UofU Patient
August 09, 2020
UH HOSPITALS AND CLINICS
Dr. Frech is amazing! She is incredibly knowledgeable, and includes me in her knowledge. She doesn't leave anything unturned and makes sure I'm comfortable with the suggestions. I feel more confident in my health outlook after meeting with her.
UofU Patient
July 26, 2020
UH HOSPITALS AND CLINICS
Dr Tracy Frech is a gift to the U of U. She is a top notch provider and always thinking outside the box. She truly listens and follows up.
Tracy M. Frech, M.D., M.S. completed a combined Internal Medicine-Pediatrics internship and residency at the University of Utah in 2005. She then finished a two-year Rheumatology fellowship in 2007 and Master in Clinical Investigation in 2009. Upon completion of her fellowship she joined the faculty in the Division of Rheumatology, and is currently an associate professor. She received a certification in Personalized Medicine in 2014.
She serves as the Director of the Systemic Sclerosis (SSc, scleroderma) Clinic at the University of Utah Hospital and the Director of Clinical Trials for the Division of Rheumatology. Her research interests include the vascular aspects of autoimmune disease, primarily vascular leak and SSc. She has participated in many government, foundation, and industry sponsored single and multi-center clinical trials. She has published over a hundred articles in peer review journals and several book chapters on SSc. She provides mentorship to medical students, with a focus on improving their early research experiences.
Academic Locations
Research Statement
Dr. Frech’s research interest is the interplay of vascular dysfunction and inflammation in the pathogenesis in Systemic Sclerosis (SSc). At the University of Utah SSc Clinic, she treats over 300 patients with this disease. She offers many clinical trials to provide patients with rheumatic disease treatment opportunities. She also participates in several national and international registries and consortia with the goal to improve early diagnosis, access to care, and standardization of testing in SSc. She is active in the Scleroderma Foundation and serves on its Medical Advisory Board.
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Adjunct Associate Professor |
| Academic Divisions | Rheumatology |
Research Interests
- Systemic Sclerosis
- Progressive Systemic Sclerosis
- Vascular Anomalies
- Vascular Malformations
- Vascular Diseases
Education History
| Other Training | University of Utah Personalized Health Care , 2014 |
| Graduate Training | University of Utah Clinical Investigation Master's, 2009 |
| Fellowship | University of Utah School of Medicine Rheumatology Fellow, 2007 |
| Residency | University of Utah School of Medicine Internal Medicine/Pediatrics Resident, 2005 |
| Internship | University of Utah School of Medicine Internal Medicine/Pediatrics Intern, 2002 |
| Professional Medical | Eastern Virginia Medical School Medicine M.D., 2001 |
| Graduate Training | Universidad de Salamanca Spanish , 1997 |
| Undergraduate | University of North Carolina Biology B.S., 1996 |
Selected Publications - Journal Articles
Journal Article
- Hughes M, Pauling JD, Jones J, Denton CP, Domsic RT, Frech TM, Herrick AL, Khanna D, Matucci-Cerinic M, McKenzie L, Saketkoo LA, Gooberman-Hill R, Moore A (2019). Patient experiences of digital ulcer development and evolution in systemic sclerosis. Rheumatology (Oxford), 59(8), 2156-2158.
- Aranow C, Cush J, Bolster MB, Striebich CC, Dallera M, Mackay M, Olech E, Frech T, Box J, Keating R, Wasko MC, St Clair W, Kivitz A, Huang W, Ricketts P, Welch B, Callahan S, Spychala M, Boyle K, York K, Keyes-Elstein L, Goldmuntz E, Diamond B, Davidson A (2019). A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford), 59(7), 1505-1513.
- Bernstein EJ, Jaafar S, Assassi S, Domsic RT, Frech TM, Gordon JK, Broderick RJ, Hant FN, Hinchcliff ME, Shah AA, Shanmugam VK, Steen VD, Khanna D (2020). Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol.
- Hughes M, Pauling JD, Jones J, Denton CP, Domsic RT, Frech TM, Herrick AL, Khanna D, Matucci-Cerinic M, McKenzie L, Saketkoo LA, Gooberman-Hill R, Moore A (2019). Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis. Arthritis Care Res (Hoboken), 72(5), 723-733.
- Spiera R, Hummers L, Chung L, Frech TM, Domsic R, Hsu V, Furst DE, Gordon J, Mayes M, Simms R, Lafyatis R, Martyanov V, Wood T, Whitfield ML, Constantine S, Lee E, Dgetluck N, White B (2020). Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis. Arthritis Rheumatol.
- Carrier ME, Kwakkenbos L, Nielson WR, Fedoruk C, Nielsen K, Milette K, Pope J, Frech T, Gholizadeh S, Hummers L, Johnson SR, Piotrowski P, Jewett L, Gordon J, Chung L, Bilsker D, Turner KA, Cumin J, Welling J, Fortune C, Leite C, Gottesman K, Sauve M, Rodrguez-Reyna TS, Hudson M, Larche M, van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Wigley F, Thombs BD, SPIN Investigators (2020). The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial. JMIR Res Protoc, 9(4), e16799.
- Harb S, Cumin J, Rice DB, Pelez S, Hudson M, Bartlett SJ, Roren A, Furst DE, Frech TM, Nguyen C, Nielson WR, Thombs BD, Shrier I, Scleroderma Patient-centered Intervention Network Physical Activity Enhancement Patient Advisory Team (2020). Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique study. Disabil Rehabil, 1-8.
- Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TM, Steen VD, Hant FN, Gordon JK, Shah AA, Zhu L, Zheng WJ, Browning JL, Barron AMS, Wu M, Visvanathan S, Baum P, Franks JM, Whitfield ML, Shanmugam VK, Domsic RT, Castelino FV, Bernstein EJ, Wareing N, Lyons MA, Ying J, Charles J, Mayes MD, Assassi S (2019). Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis, 79(3), 379-386.
- Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, Distler O, Espejo K, Foeldvari I, Frech T, Garro B, Gutierrez M, Gyger G, Hachulla E, Hesselstrand R, Iagnocco A, Kayser C, Melsens K, Mller-Ladner U, Paolino S, Pizzorni C, Radic M, Riccieri V, Snow M, Stevens W, Sulli A, van Laar JM, Vonk MC, Vanhaecke A, Cutolo M, EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy (2020). Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmun Rev, 19(3), 102458.
- Khanna D, Spino C, Johnson S, Chung L, Whitfield ML, Denton CP, Berrocal V, Franks J, Mehta B, Molitor J, Steen VD, Lafyatis R, Simms RW, Gill A, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Schiopu E, Young A, Sandorfi N, Park J, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Wang Y, Wood T, Allanore Y, Matucci-Cerinic M, Distler O, Singer O, Bush E, Fox DA, Furst DE (2019). Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Arthritis Rheumatol, 72(1), 125-136.
- Shanmugam VK, Frech TM, Steen VD, Hummers LK, Shah AA, Bernstein EJ, Khanna D, Gordon JK, Castelino FV, Chung L, Hant FN, Startup E, VanBuren JM, Evnin LB, Assassi S (2019). Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry. Clin Rheumatol, 39(1), 93-102.
- Pauling JD, Reilly E, Smith T, Frech TM (2019). Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis. J Rheumatol, 46(10), 1326-1334.
- Nagaraja V, Spino C, Bush E, Tsou PS, Domsic RT, Lafyatis R, Frech T, Gordon JK, Steen VD, Khanna D (2019). A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers. Arthritis Res Ther, 21(1), 202.
- Frech TM, Murtaugh MA (2019). Non-invasive digital thermal monitoring and flow-mediated dilation in systemic sclerosis. Clin Exp Rheumatol, 37 Suppl 119(4), 97-101.
- Zhu J, Frech T (2019). Gut disease in systemic sclerosis - new approaches to common problems. Curr Treatm Opt Rheumatol, 5(1), 11-19.
- Baron M, Kahaleh B, Bernstein EJ, Chung L, Clements PJ, Denton C, Domsic RT, Ferdowsi N, Foeldvari I, Frech T, Gordon JK, Hudson M, Johnson SR, Khanna D, McMahan Z, Merkel PA, Narain S, Nikpour M, Pauling JD, Ross L, Valenzuela Vergara AM, Vacca A (2018). An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups. J Scleroderma Relat Disord, 4(1), 17-27.
- McMahan ZH, Frech T, Berrocal V, Lim D, Bruni C, Matucci-Cerinic M, Smith V, Melsens K, Proudman S, Zhang J, Mendoza F, Woods M, Khanna D (2018). Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium. J Rheumatol, 46(1), 78-84.
- Clifton HL, Machin DR, Groot HJ, Frech TM, Donato AJ, Richardson RS, Wray DW (2018). Attenuated nitric oxide bioavailability in systemic sclerosis: Evidence from the novel assessment of passive leg movement. Exp Physiol, 103(10), 1412-1424.
- Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL (2018). Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report. J Scleroderma Relat Disord, 3(3), 249-252.
- Bruni C, Frech T, Manetti M, Rossi FW, Furst DE, De Paulis A, Rivellese F, Guiducci S, Matucci-Cerinic M, Bellando-Randone S (2018). Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed? Front Immunol, 9, 2045.
- Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, Frech TM, Ingegnoli F, Dures E, Robson J, McHugh NJ, Herrick AL, Matucci-Cerinic M, Khanna D, Hewlett S (2018). Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis. Arthritis Care Res (Hoboken), 70(9), 1373-1384.
- Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauv M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larch M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD, SPIN Investigators (2017). The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology (Oxford), 57(9), 1623-1631.
- Pauling JD, Reilly E, Smith T, Frech TM (2018). Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity. Arthritis Care Res (Hoboken).
- Frech TM, Hess R, Biber J, Young J, Hardman A, Weeks H, Peterson KA, Scholand MB (2018). Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care? J Clin Rheumatol, 24(5), 272-274.
- Morrisroe K, Hudson M, Baron M, de Vries-Bouwstra J, Carreira PE, Wuttge DM, Wang M, Frech TM, Stevens W, Proudman SM, Nikpour M, International Systemic Sclerosis Inception Cohort INSYNC collaboration (2018). Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. Clin Exp Rheumatol, 36 Suppl 113(4), 53-60.
- Frech TM, Machin DR, Murtaugh MA, Stoddard GJ, Bloom SI, Phibbs JV, Donato AJ (2018). Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment. Clin Exp Rheumatol, 36 Suppl 113(4), 175-182.
- Khanna D, Denton CP, Lin CJF, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Mller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE (2017). Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). Ann Rheum Dis, 77(2), 212-220.
- Frech TM, Mar D (2017). Gastrointestinal and Hepatic Disease in Systemic Sclerosis. Rheum Dis Clin North Am, 44(1), 15-28.
- Lebedoff N, Frech TM, Shanmugam VK, Fischer A, Erhardt D, Kolfenbach J, Kohler K, Bernhisel K, Lewis GM (2017). Review of local wound management for scleroderma-associated digital ulcers. J Scleroderma Relat Disord, 3(1), 66-70.
- Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, Denton CP, Medsger TA Jr, Carreira PE, Riemekasten G, Distler J, Gabrielli A, Steen V, Chung L, Silver R, Varga J, Mller-Ladner U, Vonk MC, Walker UA, Wollheim FA, Herrick A, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray CD, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech T, Assassi S, Saketkoo LA, Pope JE (2017). There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scand J Rheumatol, 47(1), 62-70.
- Arnold MB, Khanna D, Denton CP, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Riemekasten G, Steen V, Mller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE, Pope JE (2017). Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis. Rheumatology (Oxford), 57(1), 152-157.
- Elorreaga N, Allred D, Ortiz G, McNeill C, Scholand MB, Frech TM (2017). Implementation of an advance directive focus in a Chronic Multi-Organ Rare Disease Clinic. Ann Palliat Med, 6(Suppl 2), S206-S208.
- Machin DR, Gates PE, Vink H, Frech TM, Donato AJ (2017). Automated Measurement of Microvascular Function Reveals Dysfunction in Systemic Sclerosis: A Cross-sectional Study. J Rheumatol, 44(11), 1603-1611.
- Frech TM, Fakoya L, Gawron AJ, Wong J, Scholand MB, Sawitzke A, Peterson K (2017). Oesophageal disease in systemic sclerosis: does heritability play a role? Clin Exp Rheumatol, 35 Suppl 106(4), 86-88.
- Machin DR, Clifton HL, Richardson RS, Wray DW, Donato AJ, Frech TM (2017). Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis. Clin Exp Rheumatol, 35 Suppl 106(4), 167-172.
- Allred D, Frech TM, McComber C, Peterson K, Ortiz G, McNeill C, Broadbent L, Elorreaga N, Miller T, Scholand MB (2019). Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team. J Med Pract Manage, 32(6), 413-416.
- Li W, Frech TM (2017). The critical need for accurately defining digital ulcers in scleroderma. J Scleroderma Relat Disord, 2(2), 69-71.
- Goldberg A, Geppert T, Schiopu E, Frech T, Hsu V, Simms RW, Peng SL, Yao Y, Elgeioushi N, Chang L, Wang B, Yoo S (2014). Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study. Arthritis Res Ther, 16(1), R57.
- Frech TM, Smith G, Reily M, Chamberlain J, Murtaugh MA, Penrod J, Battistone MJ, Stults BM (2013). Peripheral neuropathy: a complication of systemic sclerosis. Clin Rheumatol, 32(6), 885-8.
- Frech TM, Penrod J, Battistone MJ, Sawitzke AD, Stults BM (2012). The prevalence and clinical correlates of an auscultatory gap in systemic sclerosis patients. Int J Rheumatol, 2012, 590845.
- Frech T, Coffin C, Bohnsack JF, Prahalad S (2006). Concurrent occurrence of eosinophilic fasciitis and morphea in two children. Pediatr Rheumatol Online J, 4(1).
Conference Proceedings
Letter
- Pauling JD, Frech TM (2019). Pauling and Frech reply. [Letter to the editor]. J Rheumatol, 46(11), 1544-1545.
- Tebo AE, Schmidt RL, Frech TM (2019). Dr. Tebo, et al, reply. [Letter to the editor]. J Rheumatol, 46(11), 1547.
- Snow MH, Saketkoo LA, Frech TM, Stever JR, Lebedoff N, Herrick AL, Cutolo M, Smith V (2019). Results from an American pilot survey among Scleroderma Clinical Trials Consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training. [Letter to the editor]. Clin Exp Rheumatol, 37 Suppl 119(4), 151.
- Frech TM, McNeill C, Lebiedz-Odrobina D, Lewis G (2018). Amniotic membrane dressings: an effective therapy for SSc-related wounds. [Letter to the editor]. Rheumatology (Oxford), 58(4), 734-736.
- Tebo AE, Schmidt RL, Frech TM (2019). Presence of Antitopoisomerase I Antibody Alone May Not Be Sufficient for the Diagnosis of Systemic Sclerosis. [Letter to the editor]. J Rheumatol, 46(4), 440-442.
Global Impact
Education History
| Graduate Training | Universidad de Salamanca Spanish |